Ruud Dobber

Ruud Dobber

Director/Board Member at ALMIRALL, S.A.
Health Technology
Consumer Services
Commercial Services

Profile

Ruud Dobber is currently an Independent Director at Almirall SA since 2021.
Dr. Dobber is also a Director at Alexion Pharmaceuticals, Inc., Caelum Biosciences, Inc., and AstraZeneca Ireland Ltd. Formerly, Dr. Dobber was Chairman-Asia Division at Pharmaceutical Research & Manufacturers of America, Director at European Federation of Pharmaceutical Industries & Assns, President at AstraZeneca, Inc., and Executive Vice President-North America at AstraZeneca PLC from 1997 to 2019.
Education includes a doctorate from the University of Leiden and a graduate degree from the University of Utrecht.

Ruud Dobber active positions

CompaniesPositionStart
ALMIRALL, S.A. Director/Board Member 18/06/2021
ALEXION PHARMACEUTICALS, INC. Director/Board Member -
Director/Board Member -

Former positions of Ruud Dobber

CompaniesPositionEnd
President -
Director/Board Member -
Corporate Officer/Principal -
ASTRAZENECA PLC Corporate Officer/Principal -
See the detail of Ruud Dobber's experience

Training of Ruud Dobber

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

44

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!